Enhance profits using AI-supported chromosome testing in China
Hangzhou Diagens Biotechnology aims to boost its profits through AI-supported chromosome testing following its listing in Hong Kong. This initiative comes amidst a declining fertility rate in China and an increasing demand for assisted reproductive services.